2.9. Antiplatelet drugsSee the NHSGGC Antiplatelet Guidelines for appropriate use of the following medicines. The existing guideline is available on the Clinical Guidelines store on StaffNet.
Aspirin enteric coated (EC) is not included in the Formulary and should not be used as the formulation does not reduce GI symptoms. If the patient experiences new gastro-intestinal symptoms, consider other contributory factors (e.g. alcohol intake or NSAID use) and then consider gastro-protection (e.g. omeprazole or lansoprazole).
Restrictions: Restricted to use in accordance with the NHSGGC Guidelines for the Secondary Prevention of Stroke and TIA
Restrictions: Restricted to use in accordance with NHSGGC Antiplatelet Guidelines
Ticagrelor, co-administered with aspirin is restricted to specialist initiation for the prevention of atherothrombotic events in selected patient groups as outlined below.
Use in the following patient groups is Formulary.
- adult patients with ST elevation myocardial infarction [STEMI]
- adult patients with non ST elevation myocardial infarction [NSTEMI]
- patients who are either allergic or intolerant to clopidogrel or for those patients who have a stent thrombosis on clopidogrel
A patient/GP information leaflet is available.
Use in combination with aspirin for the prevention of atherothrombotic events in adults with a history of myocardial infarction and a high-risk of developing an atherothrombotic event is not recommended by SMC and is non-Formulary.
Restrictions: Restricted to use by consultant cardiologists.
Restrictions: Restricted to use by consultant cardiologists in high risk and unstable patients undergoing a variety of percutaneous coronary interventions.